A Study in People With High Cholesterol
- Conditions
- Hypercholesterolemia
- Registration Number
- NCT00133380
- Lead Sponsor
- Eli Lilly and Company
- Brief Summary
The purposes of this study are to determine:
* The safety of the study medication and any side effects that might be associated with it
* Whether the study medication can help patients with high levels of "bad" cholesterol (low-density lipoprotein-cholesterol \[LDL-C\]), alone or in combination with additional study medication
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
- Men and women between 18 and 80 years of age
- People with abnormal cholesterol levels
- People with diabetes
- People whose blood pressure >160/95 mm Hg, on or off blood pressure medicine
- People who have had frequent chest pain or unstable angina, a heart attack or a heart procedure including stent placement, within the past 3 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Effects on "bad" cholesterol, LDL-C, after 12 weeks
- Secondary Outcome Measures
Name Time Method Evaluate safety after 12 weeks Effects on other lipids and biomarkers associated with atherosclerosis after 12 weeks Evaluate interaction of the 2 different study medications
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
🇺🇸Kingsport, Tennessee, United States